1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, December 2015 (p10)

General Medicine and Specialty Medicine Analysis & Statistics, December 2015 (p10)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

271-300 of about 3 600 reports

Purchase Reports From Reputable Market Research Publishers

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Pancreatic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2015

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2015’, provides an overview of the Bile ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Glaucoma - Pipeline Review, H2 2015

Glaucoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Glaucoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H2 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Healthcare
  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Metastatic Melanoma - Pipeline Review, H2 2015

Metastatic Melanoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Metastatic Melanoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Partial Seizure - Pipeline Review, H2 2015

Partial Seizure - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Partial Seizure - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H2 2015’, provides an overview of the Partial Seizure’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Soft Tissue Sarcoma - Pipeline Review, H2 2015

Soft Tissue Sarcoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Soft Tissue Sarcoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H2 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Myelodysplastic Syndrome - Pipeline Review, H2 2015

Myelodysplastic Syndrome - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H2 2015’, provides an overview of the Myelodysplastic Syndrome’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
High-Grade Glioma - Pipeline Review, H2 2015

High-Grade Glioma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

High-Grade Glioma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H2 2015’, provides an overview of the High-Grade Glioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Small-Cell Lung Cancer - Pipeline Review, H2 2015

Small-Cell Lung Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Small-Cell Lung Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Neuroblastoma - Pipeline Review, H2 2015

Neuroblastoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H2 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Macular Edema - Pipeline Review, H2 2015

Macular Edema - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Macular Edema - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Macular Edema - Pipeline Review, H2 2015’, provides an overview of the Macular Edema’s therapeutic pipeline. This report ...

  • Industries : Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States, World
Ewing Sarcoma - Pipeline Review, H2 2015

Ewing Sarcoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Ewing Sarcoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H2 2015’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Burkitt Lymphoma - Pipeline Review, H2 2015

Burkitt Lymphoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Burkitt Lymphoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Burkitt Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Lung Adenocarcinoma - Pipeline Review, H2 2015

Lung Adenocarcinoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Lung Adenocarcinoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H2 2015’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Malignant Mesothelioma - Pipeline Review, H2 2015

Malignant Mesothelioma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Malignant Mesothelioma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Migraine - Pipeline Review, H2 2015

Migraine - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Migraine - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Migraine - Pipeline Review, H2 2015’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Anaplastic Astrocytoma - Pipeline Review, H2 2015

Anaplastic Astrocytoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Anaplastic Astrocytoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H2 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Cataract - Pipeline Review, H2 2015

Cataract - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Cataract - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Cataract - Pipeline Review, H2 2015’, provides an overview of the Cataract’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical
  • Countries : United States
Ischemia - Pipeline Review, H2 2015

Ischemia - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Ischemia - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Ischemia - Pipeline Review, H2 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
Hairy Cell Leukemia - Pipeline Review, H2 2015

Hairy Cell Leukemia - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Hairy Cell Leukemia - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2015’, provides an overview of the Hairy Cell Leukemia’s therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : United States
Retinal Vein Occlusion - Pipeline Review, H2 2015

Retinal Vein Occlusion - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Retinal Vein Occlusion - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H2 2015’, provides an overview of the Retinal Vein Occlusion’s therapeutic ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Retinal Degeneration - Pipeline Review, H2 2015

Retinal Degeneration - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Retinal Degeneration - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Retinal Degeneration - Pipeline Review, H2 2015’, provides an overview of the Retinal Degeneration’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, Europe, World
Salivary Gland Cancer - Pipeline Review, H2 2015

Salivary Gland Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Salivary Gland Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Salivary Gland Cancer - Pipeline Review, H2 2015’, provides an overview of the Salivary Gland Cancer’s therapeutic ...

  • Industries : Pathology
  • Countries : United States
Thymus Cancer - Pipeline Review, H2 2015

Thymus Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Thymus Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Thymus Cancer - Pipeline Review, H2 2015’, provides an overview of the Thymus Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Posterior Uveitis - Pipeline Review, H2 2015

Posterior Uveitis - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Posterior Uveitis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Posterior Uveitis - Pipeline Review, H2 2015’, provides an overview of the Posterior Uveitis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Corneal Neovascularization - Pipeline Review, H2 2015

Corneal Neovascularization - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Corneal Neovascularization - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Corneal Neovascularization - Pipeline Review, H2 2015’, provides an overview of the Corneal Neovascularization’s ...

  • Industries : Pathology
  • Countries : United States
Corneal Ulcers - Pipeline Review, H2 2015

Corneal Ulcers - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Corneal Ulcers - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Corneal Ulcers - Pipeline Review, H2 2015’, provides an overview of the Corneal Ulcers’s therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Global Nuclear Medicine Outlook 2020

Global Nuclear Medicine Outlook 2020

  • $ 2 000
  • Industry report
  • December 2015
  • by RNCOS

Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective ...

  • Industries : General Medicine and Specialty Medicine, Diagnostics, Diagnostics, Medical Imaging, Medical Imaging
  • Countries : World

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.